Skip to main content
. Author manuscript; available in PMC: 2015 Jun 25.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jan 25;22(4):580–588. doi: 10.1158/1055-9965.EPI-12-1266

Table 4.

Multivariate analysis of characteristics associated with Pap test screening in the last 12 months among women ages 18–29 years, NHIS, 2010 (n = 1,622)

Most recentPap test ≤ 12 moa
OR (95% CI) P (Wald-F)
Age, y 0.086
 18–21 1.54 (1.03–2.31b)
 22–25 1.24 (0.92–1.69)
 26–29 1.00
Healthcare coverage 0.219
 Private only 1.00
 Public onlyc 1.57 (0.93–2.66)
 Both private and public 1.13 (0.79–1.61)
 None 0.99 (0.66–1.48)
Usual source of healthcare 0.002
 Yes 1.64 (1.20–2.25)
 No 1.00
Ever heard of HPV 0.620
 Yes 1.09 (0.77–1.54)
 No 1.00
Ever given birth to a live born infant 0.534
 Yes 0.90 (0.64–1.26)
 No 1.00
Currently taking birth controld <0.001
 Yes 2.31 (1.74–3.06)
 No 1.00
Doctor recommended most recent Pap teste 0.094
 Yes 0.96 (0.72–1.29)
 No 1.00

NOTE: Excludes women reporting hysterectomy, women who report an abnormal Pap in last 3 years, and women who reported their last Pap was not part of a regular screening examination. To construct our multivariable model, we conducted a separate bivariate analysis comparing last Pap test reported within 12 versus 13–36 months (data not shown). Statistically significant variables with P < 0.05 from this separate bivariate analysis were included in the multivariate analysis. as covariates.

a

Among women who have ever had a Pap, odds of reporting most recent Pap within 12 months, compared to all other intervals (>1–2, >2–3, >3–5, >5years).

b

Because the confidence interval does not overlap the referent group, we ran a contrast test for 18–21 versus 26–29 and the Wald-F P = 0.036.

c

Medicare, Medicaid (Military defined as private).

d

Pills, implants, shots.

e

Response “Did not see a doctor on the past 12 months” included in analysis, but suppressed in this table.